PharmaBoardroom

Medtech Firms’ Saudi Strategies

Saudi Arabia is seeing an increased demand for more innovative medical devices and a greater awareness of the myriad ways that medical technology can…

Alper Ureten – VP, General Manager for Biosimilars…

Alper Ureten, Amgen VP and General Manager, sits down with PharmaBoardroom to set out his ambitions and objectives for its Biosimilars Business Unit.…

US Prescription Drug Pricing: “The Times They Are A Changin”

Ulrich Neumann examines the debate around drug pricing in the US and why it is not going away any time soon. Come senators, congressmen…

Christoph Stoller – President & Adrian van den Hoven…

In the wake of the publication of Medicines for Europe’s Lessons Learned from COVID-19 policy paper, Christoph Stoller & Adrian van den Hoven…

Can We Afford to Pay for Future Cures?

Pharmaceutical innovation is racing ahead of the US health system's ability to adjust payment models, but innovative concepts are finally emerging. We…

Jin LI – Chairman & CEO, HitGen, China

Dr Jin Li explains Chinese firm HitGen’s unique drug discovery technology platform, how its ability to screen billions of molecules has the…

China Pharma News Roundup July 14th 2020

A roundup of the latest from Chinese pharma and biotech, including Boehringer Ingelheim’s new Shanghai R&D hub, new HKEX IPO successes for…

Jeong-Sun Seo – Chairman, Macrogen & President, KoreaBIO

Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO), explains the basis for Korea’s…

Six Indian Companies at the Forefront of COVID-19 Vaccine…

Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with India-developed vaccine candidates moving…

Exploring New & Repurposed Tools in the Fight Against…

Dr Sophia Ononye-Onyia explains why a combination of both repurposed drugs and emerging technologies like 3D bioprinting and artificial intelligence…

China Pharma News Roundup June 29th 2020

The latest news from Chinese pharma, including the latest on Sinopharm’s COVID-19 vaccine, how geopolitical tensions are affecting trade between…

Opinion: The Chinese Doctor-Patient Relationship in the Digital…

I recently had the pleasure to moderate an event on the COVID-19 impact on the relationship between Doctor and Patient, attended by 50 executives of…

Tagged with BI